Navigation Links
How to Select an Electronic Health Record System That Healthcare Professionals Can Use
Date:2/5/2009

CHICAGO, Feb. 5 /PRNewswire/ -- In recent years, Electronic Health Records (EHRs) have been promoted by industry and government as a means of improving patient care and controlling costs. However, actual adoption of EHRs has been lower than expected due to general resistance related to implementation costs, security, privacy, and systems integration. Recent studies have shown, however, that many of these adoption barriers pale in comparison to basic usability and productivity concerns. Simply put, healthcare professionals have found many EHRs too difficult to use.

Why has EHR usability remained an issue even as more organizations deploy these systems? To explore this topic, the Chicago-based user research firm User Centric inspected dozens of publicly available Requests for Proposal and procurement guidelines for EHRs to learn how usability was addressed. This inspection revealed that EHR usability was overlooked or only marginally mentioned in nearly all of the documents. Only three documents discussed usability or user experience in any substantive way. Thus, there was a gap between the need for improved usability in EHRs and a lack of usability criteria in the EHR procurement cycle.

To bridge this gap, User Centric proposes an approach for specifying usability requirements and assessing EHR systems relative to these requirements. The User Centric white paper, "How to Select an Electronic Health Record System the Healthcare Professionals Can Use," identifies a five-step process for specifying and measuring the usability of EHR systems. These steps are intended to help guide selection of an EHR that meets the criteria for high levels of effectiveness, efficiency, and subjective satisfaction among healthcare providers. User Centric believes that EHR systems selected in this manner
'/>"/>

SOURCE User Centric, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Delfigo Security Selected as One of Twenty Five Most Promising Startups by The Wharton Entrepreneurship Conference
2. Dallas – Fort Worth Bariatric Surgeon Dr. David Kim One of Few in America Selected to Perform New Weight Loss Surgery Procedure
3. Wesley Mosley Selected to Participate in Global Youth Activation Summit During the 2009 Special Olympics World Winter Games
4. Danaher to Present at Barclays Capital Industrial Select Conference
5. EDI Health Group Selected by Quality Systems to Facilitate EDI Transactions Between Payers and Large Dental Group Practices
6. Texcel Selects Tiziani Whitmyre for Public Relations, Internet Marketing Services
7. Columbia Doctors, the Physicians and Surgeons of Columbia University Select MxSecure, Inc., as Their Medical Transcription Vendor of Choice
8. CMS Selects Thomson Reuters to Help Implement Medicare Medical Home Demonstration Project for Medicare Recipients
9. Blue Cross and Blue Shield of Florida Partners with Community Providers to Offer Low-Cost BlueSelect Health Plan for Hillsborough and Pinellas Counties
10. E-VERIFILE.COM, Inc. Selects Medium Blue Search Engine Marketing to Highlight Its Innovative Screening and Hiring Solutions with Search Engine Optimization and Online PR
11. Its Cold Outside! Warm Up in Select Downtown Boston Heated Bus Shelters Courtesy of TYLENOL(r) Warming Liquids

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)..., NEWYORK,Nov.24/PRNewswire-USNewswire/--Thereisan...s.Itisharmreduction,offeringpragmaticandrealistics...mshavefailed.Spearheadingthismovementisagroupcalle...nSupport.HAMSisafree-of-charge,lay-ledsupportandin...eNationalInstituteonAlcoholAbuseandAlcoholismtells...
(Date:11/24/2009)..., ChangesMustBeMadetoUSPSTFRepresentationandRecom...re-USNewswire/-- SeveralsectionsofSenatehealthcare...suranceentitiessuchasprivateinsurers,MedicareandMe...specificgradefromtheU.S.PreventativeServicesTaskFo...orwomen40-49,wouldonlyrequirecoverageofbiennial(ev...
(Date:11/24/2009)...ANAPOLIS Involving family members of pediatric ca...efits both the family and the medical team, accord... study. , Riley Hospital for Children, where th...number of hospitals nationwide routinely offering ...ients the opportunity to join their child,s medica...
(Date:11/24/2009)...rom less-affluent families are at higher risk, stu... News) -- Although children from poorer families w...f accidental injuries, child care could actually p...uggests. , In the report, published online Nov....Health , researchers looked at a study of 14,000 c...
(Date:11/24/2009)... zioTerm Software will be Offer...ies , (PRWEB) -- Ziosoft&...analysis software for medical imaging, is offering...to the academic and research communities. The Win... DICOM 3.0-compatible imaging data from CT, MR, PE...
Breaking Medicine News(10 mins):Health News:Harm Reduction for Alcohol: An Idea Whose Time Has Arrived 2Health News:USPSTF Mammography Recommendations Should Be Specifically Excluded From Health Care Reform Legislation 2Health News:USPSTF Mammography Recommendations Should Be Specifically Excluded From Health Care Reform Legislation 3Health News:Involving family in medical rounds benefits both family and medical team 2Health News:Involving family in medical rounds benefits both family and medical team 3Health News:Involving family in medical rounds benefits both family and medical team 4Health News:Ziosoft Releases Free zioTerm Basic 2D/3D Software Application 2
...,HearAtLast Holdings, Inc. is proud to announce th...Canada (NYSE: WMT ) to open its 16th hearing-aid,...ted at 255 Silver Linden,Dr. in Richmond Hill, Ont... option under a master licensing agreement with,Wa...
...dard being adopted worldwide by, pharmaceutical an...firming digital identiti...Nasdaq: ALDN ), an information security leader sp...dware product,to be certified under the recently e...
...rse Expertise, MIAMI, Dec. 9 Novis Pharmaceutica...ts to healthcare providers, is pleased,to announce...esident of,Human Resources. Ms. Lopez was most rec...g from Florida International,University (FIU). She...
...e of colorectal cancer screening procedures among ...e January 15, 2008 issue of CANCER, a peer-reviewe...t only 25 percent of Medicare patients received re...tes. The American Cancer Society estimates that in...
...ieve or disbelieve a statement is a powerful force...e basis of these states in the brain is not yet un... and uncertainty activate distinct regions of the ... Annals of Neurology ( http://www.interscience.wil...
... improved pre, - and post-stem cell transplantati... dexamethasone -, ATLANTA, Dec. 9 ...reported the presentation of results from an inter...examethasone (VcTD) to thalidomide and dexamethaso...
Other Medicine News:Health News:HearAtLast Continues Expansion Announcing Opening of New Clinic Location in Sam's Club in Richmond Hill, Ontario 2Health News:HearAtLast Continues Expansion Announcing Opening of New Clinic Location in Sam's Club in Richmond Hill, Ontario 3Health News:HearAtLast Continues Expansion Announcing Opening of New Clinic Location in Sam's Club in Richmond Hill, Ontario 4Health News:Aladdin eToken First Strong Authentication Device to Achieve Certification from the SAFE-BioPharma Association 2Health News:Aladdin eToken First Strong Authentication Device to Achieve Certification from the SAFE-BioPharma Association 3Health News:Aladdin eToken First Strong Authentication Device to Achieve Certification from the SAFE-BioPharma Association 4Health News:Novis Pharmaceuticals Hires Lisa Lopez 2Health News:Many Medicare beneficiaries not receiving colorectal cancer screening 2Health News:Belief, disbelief and uncertainty activate distinct brain regions 2Health News:Phase III Trial of VELCADE(R) (Bortezomib) for Injection Showed Dramatic Fourfold Increase in Complete Remission Rates When Combined With the Most Commonly Used U.S. Regimen in Front-Line Multiple Myeloma 2Health News:Phase III Trial of VELCADE(R) (Bortezomib) for Injection Showed Dramatic Fourfold Increase in Complete Remission Rates When Combined With the Most Commonly Used U.S. Regimen in Front-Line Multiple Myeloma 3Health News:Phase III Trial of VELCADE(R) (Bortezomib) for Injection Showed Dramatic Fourfold Increase in Complete Remission Rates When Combined With the Most Commonly Used U.S. Regimen in Front-Line Multiple Myeloma 4Health News:Phase III Trial of VELCADE(R) (Bortezomib) for Injection Showed Dramatic Fourfold Increase in Complete Remission Rates When Combined With the Most Commonly Used U.S. Regimen in Front-Line Multiple Myeloma 5Health News:Phase III Trial of VELCADE(R) (Bortezomib) for Injection Showed Dramatic Fourfold Increase in Complete Remission Rates When Combined With the Most Commonly Used U.S. Regimen in Front-Line Multiple Myeloma 6
(Date:11/23/2009).../--HealthWarehouse.com,Inc.(OTCBulletinBoard:HEWA)...nancialresultsforthethirdquarterendedSeptember30,2...,drivenbyheavygrowthinprescriptionsalesandpharmacy...to34.6%andthenetlossforthequarterwas$619,114compar...ber30,2008. ,, "Wecontinuetoseeconsumerstransfe...
(Date:11/23/2009)...ll/--BostonScientificCorporation(NYSE: BSX )issche...rence,December1-2. ,, RayElliott,PresidentandCh...ntandChiefFinancialOfficer,willparticipateina30-mi...,beginningatapproximately9:00a.m.E.T. ,, Alivew...edpartiesatBostonScientific,swebsiteat www.bostons...
(Date:11/23/2009)...FirstCall/--BeckmanCoulter,Inc.(NYSE: BEC ),aleadi...simplify,automate,andinnovatecomplexbiomedicaltest...vicepresidentofstrategy,willpresentatthePiperJaffr...12:00p.m.(ET). ,, (Logo: http://www.newscom.com...astofBeckmanCoulter,spresentationcanbeaccessedbyvi...
Breaking Medicine Technology:HealthWarehouse.com, Inc. Announces Third Quarter Financial Results; Revenues, Margins, and Orders Shipped Increase Over Third Quarter 2008 2HealthWarehouse.com, Inc. Announces Third Quarter Financial Results; Revenues, Margins, and Orders Shipped Increase Over Third Quarter 2008 3Nuvilex Offers Free Cinnergen Samples in Response to Spike in Consumer Interest 48041 1Nuvilex Offers Free Cinnergen Samples in Response to Spike in Consumer Interest 48041 2Nuvilex Offers Free Cinnergen Samples in Response to Spike in Consumer Interest 48041 3National Survey Finds Nearly All Adults Say They Wash Their Hands After Visiting Public Restrooms But Most Think They Are Exception 48038 1National Survey Finds Nearly All Adults Say They Wash Their Hands After Visiting Public Restrooms But Most Think They Are Exception 48038 2National Survey Finds Nearly All Adults Say They Wash Their Hands After Visiting Public Restrooms But Most Think They Are Exception 48038 3National Survey Finds Nearly All Adults Say They Wash Their Hands After Visiting Public Restrooms But Most Think They Are Exception 48038 4Senior Citizens Bureau Creates New Resourceful Divisions 48034 1Senior Citizens Bureau Creates New Resourceful Divisions 48034 2
... and CAMBRIDGE Massachusetts, July 3, - Shire p...ni AG for an equity purchase price of EUR328 mill...IRAZYR(R), to its Human Genetic Therapies (HGT) po...ted to be around $350-400 million, based on curre...Expected to be accretive for Non GAAP earnings by ...
...ay Dosing Regimen sNDA Targeted for Fiscal Year-en...F LAKE, N.J., July 1, 2008 Eisai Corporation of,N...acy data from a trial,initiated in 2002 comparing ...SC) in elderly patients with myelodysplastic syndr...ically significant advantage of Dacogen,treatment ...
Other Medicine Technology:Shire to add New Orphan Drug to its HGT Portfolio - EU Launch Imminent 2Shire to add New Orphan Drug to its HGT Portfolio - EU Launch Imminent 3Shire to add New Orphan Drug to its HGT Portfolio - EU Launch Imminent 4Shire to add New Orphan Drug to its HGT Portfolio - EU Launch Imminent 5Shire to add New Orphan Drug to its HGT Portfolio - EU Launch Imminent 6Shire to add New Orphan Drug to its HGT Portfolio - EU Launch Imminent 7Shire to add New Orphan Drug to its HGT Portfolio - EU Launch Imminent 8Eisai Provides Preliminary Efficacy Update On EORTC Phase III Trial of Dacogen(R) Versus Supportive Care in Patients With Myelodysplastic Syndromes 2Eisai Provides Preliminary Efficacy Update On EORTC Phase III Trial of Dacogen(R) Versus Supportive Care in Patients With Myelodysplastic Syndromes 3Eisai Provides Preliminary Efficacy Update On EORTC Phase III Trial of Dacogen(R) Versus Supportive Care in Patients With Myelodysplastic Syndromes 4
Clearview IM
SureStep LH
Clearview Exact Strep A Cassette
Careplan VpH Test Gloves
Medicine Products: